BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11595346)

  • 1. Functional characterization of the splicing variants of human norepinephrine transporter.
    Kitayama S; Morita K; Dohi T
    Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional importance of the C-terminus of the human norepinephrine transporter.
    Distelmaier F; Wiedemann P; Brüss M; Bönisch H
    J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
    Paczkowski FA; Bönisch H; Bryan-Lluka LJ
    Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterization of the novel isoforms of bovine norepinephrine transporter produced by alternative splicing.
    Kitayama S; Kumagai K; Morita K; Dohi T
    Brain Res; 2002 May; 934(2):152-6. PubMed ID: 11955478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
    Hahn MK; Robertson D; Blakely RD
    J Neurosci; 2003 Jun; 23(11):4470-8. PubMed ID: 12805287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
    Mash DC; Ouyang Q; Qin Y; Pablo J
    J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
    Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
    J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine.
    Zhu MY; Blakely RD; Apparsundaram S; Ordway GA
    J Neurochem; 1998 Apr; 70(4):1547-55. PubMed ID: 9523572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
    Sucic S; Bryan-Lluka LJ
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
    Sucic S; Bryan-Lluka LJ
    J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
    Paczkowski FA; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):312-7. PubMed ID: 11919656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.
    Melikian HE; McDonald JK; Gu H; Rudnick G; Moore KR; Blakely RD
    J Biol Chem; 1994 Apr; 269(16):12290-7. PubMed ID: 8163533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
    Strauss MJ; Porter KD; Quizon PM; Davis SE; Lin S; Yuan Y; Martinez-Muniz GA; Sun WL; Zhan CG; Zhu J
    PLoS One; 2022; 17(9):e0275182. PubMed ID: 36170295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.
    Mandela P; Chandley M; Xu YY; Zhu MY; Ordway GA
    Neurochem Int; 2010; 56(6-7):760-7. PubMed ID: 20176067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity.
    Bauman PA; Blakely RD
    Arch Biochem Biophys; 2002 Aug; 404(1):80-91. PubMed ID: 12127072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.
    Galli A; DeFelice LJ; Duke BJ; Moore KR; Blakely RD
    J Exp Biol; 1995 Oct; 198(Pt 10):2197-212. PubMed ID: 7500004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.
    Zhen J; Ali S; Dutta AK; Reith ME
    J Neurosci Methods; 2012 Jan; 203(1):19-27. PubMed ID: 21933682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
    Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
    J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.